Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth

被引:72
作者
Carletto, Bruna [1 ]
Berton, Juliana [1 ]
Ferreira, Tamara Nascimento [1 ]
Dalmolin, Luciana Facco [1 ]
Paludo, Katia Sabrina [2 ]
Mainardes, Rubiana Mara [3 ]
Farago, Paulo Vitor [4 ]
Favero, Giovani Marino [5 ]
机构
[1] Midwestern State Univ, Ponta Grossa State Univ, Postgrad Program Pharmaceut Sci, Brasilia, DF, Brazil
[2] Univ Estadual Ponta Grossa, Dept Struct Mol & Genet Biol, Ponta Grossa, PR, Brazil
[3] Midwestern State Univ, Dept Pharm, Brasilia, DF, Brazil
[4] Univ Estadual Ponta Grossa, Dept Pharmaceut Sci, Ponta Grossa, PR, Brazil
[5] Univ Estadual Ponta Grossa, Dept Gen Biol, BR-84030900 Ponta Grossa, Parana, Brazil
关键词
B16F10 Cell line; Nanoparticles; PCL; Phytoalexin; Polymeric drug carrier; DRUG-DELIVERY; IN-VIVO; NANOPARTICLES; PHARMACOKINETICS; ANTICANCER; CELLS; MECHANISMS; APOPTOSIS; THERAPY; BLEND;
D O I
10.1016/j.colsurfb.2016.04.001
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this study, resveratrol-loaded nanocapsules were developed and its antitumor activity tested on a melanoma mice model. These nanocapsules were spherically-shaped and presented suitable size, negative charge and high encapsulation efficiency for their use as a modified-release system of resveratrol. Nanoencapsulation leads to the drug amorphization. Resveratrol-loaded nanoparticles reduced cell viability of murine melanoma cells. There was a decrease in tumor volume, an increase in the necrotic area and inflammatory infiltrate of melanoma when resveratrol-loaded nanocapsules were compared to free resveratrol in treated mice. Nanoencapsulation of resveratrol also prevented metastasis and pulmonary hemorrhage. This modified-release technology containing resveratrol can be used as a feasible approach in order to inhibit murine melanoma tumor growth. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 56 条
[41]   Recent Advances in the Study on Resveratrol [J].
Nakata, Rieko ;
Takahashi, Satoru ;
Inoue, Hiroyasu .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (03) :273-279
[42]  
Neves AR, 2012, CURR MED CHEM, V19, P1663
[43]   Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma [J].
Olszanski, Anthony J. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (04) :346-356
[44]   Enhancing Melanoma Treatment with Resveratrol [J].
Osmond, Gregory W. ;
Augustine, Christina K. ;
Zipfel, Patricia A. ;
Padussis, James ;
Tyler, Douglas S. .
JOURNAL OF SURGICAL RESEARCH, 2012, 172 (01) :109-115
[45]   Resveratrol: review on therapeutic potential and recent advances in drug delivery [J].
Pangeni, Rudra ;
Sahni, Jasjeet K. ;
Ali, Javed ;
Sharma, Shrestha ;
Baboota, Sanjula .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (08) :1285-1298
[46]   Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles [J].
Panyam, J ;
Williams, D ;
Dash, A ;
Leslie-Pelecky, D ;
Labhasetwar, V .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (07) :1804-1814
[47]   Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging [J].
Parveen, Suphiya ;
Misra, Ranjita ;
Sahoo, Sanjeeb K. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (02) :147-166
[48]   Resveratrol-Loaded Nanoparticles Based on Poly(epsilon-caprolactone) and Poly(D,L-lactic-co-glycolic acid)-Poly(ethylene glycol) Blend for Prostate Cancer Treatment [J].
Sanna, Vanna ;
Siddiqui, Imtiaz Ahmad ;
Sechi, Mario ;
Mukhtar, Hasan .
MOLECULAR PHARMACEUTICS, 2013, 10 (10) :3871-3881
[49]   Cancer statistics, 2013 [J].
Siegel, Rebecca ;
Naishadham, Deepa ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2013, 63 (01) :11-30
[50]   Resveratrol as an anticancer nutrient: molecular basis, open questions and promises [J].
Signorelli, P ;
Ghidoni, R .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2005, 16 (08) :449-466